drugset / Trial / NCT00326053

Prevention of Asthma Relapse After Discharge From Emergency

NCT00326053 ↗

Phase 3 Completed 600 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the Symbicort® Turbuhaler® to both Pulmicort® Turbuhaler® and Bricanyl® Turbuhaler® for the treatment of asthma after discharge from the emergency room

Timeline

Start
2006-05
Primary completion
—
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 160 ug Inhaled
Subject Formoterol Other / unclassified 4.5 ug Inhaled

Indications